Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Immunoregulation by lysophosphatidylcholine: mechanisms, determinants, and therapeutics.

Created on 19 Nov 2026

Authors

Xin Yu, Ruitong Zhang, Hongwei Zhu, Peixiang Lan, Xingxiao Zhang

Published in

Trends in pharmacological sciences. Nov 18, 2026. Epub Nov 18, 2026.

Abstract

Lysophosphatidylcholine (LPC) is a bioactive lysophospholipid and circulating metabolite that is increasingly recognized as an important regulator of immune responses and tissue homeostasis. However, its immunoregulatory effects are diverse and sometimes opposing across cell types and disease contexts, and the factors underlying this variability remain to be examined. Advances in structural biology, lipidomics, and lipid metabolism provide new insights into how LPC's molecular structure, its interactions with membrane proteins, and its metabolic fate shape its biological effects and contribute to disease processes. In this article, we review the mechanisms by which LPC regulates membrane proteins, the factors determining its immunoregulatory effects, and therapeutic strategies targeting LPC and its metabolic pathways.

PMID:
43052120
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement